Jalra-DP Tablet is an antidiabetic medicine used to treat type II diabetes. Type II Diabetes Mellitus is characterised by high blood sugar levels due to insulin resistance or insulin deficiency.

Jalra-DP Tablet contains Dapagliflozin (sodium-glucose cotransporter-2 inhibitors) and Vildagliptin (dipeptidyl peptidase-4 inhibitor), which work by increasing the amounts of certain natural substances that lower blood sugar when it is high.

Jalra-DP Tablet may cause certain side effects, such as vomiting, nausea, dizziness, abdominal pain, headache, frequent urination, and allergic reactions. If these side effects persist or worsen, please consult your doctor.

Jalra-DP Tablet should be avoided if you are allergic to any of its components. Inform your doctor about your medical history and the medicines you are taking, including herbs and supplements, before starting the treatment with Jalra-DP Tablet .

Jalra-DP Tablet is used in the treatment of Type II Diabetes Mellitus. The detailed uses of Jalra-DP Tablet are as follows:

• Supports blood sugar control in type 2 diabetes: Jalra-DP Tablet helps improve glycemic control through multiple complementary actions.
• Enhances insulin release and reduces glucagon: Jalra-DP Tablet stimulates insulin secretion after meals and suppresses the hormone that increases blood sugar, helping regulate glucose more effectively.
• Increases urinary glucose excretion: Jalra-DP Tablet works through the kidneys to prevent reabsorption of sugar into the bloodstream, allowing excess glucose to be expelled through urine.
• Improves long-term glucose management: By acting on different pathways in the body, Jalra-DP Tablet supports consistent blood sugar control and helps reduce the risk of diabetes-related complications over time.

• Take Jalra-DP Tablet with or without food or as advised by a doctor.
• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Swallow the medicine as a whole with a glass of water.
• Do not crush, break, or chew it.

• Jalra-DP Tablet is a combination of two antidiabetic medicines: Dapagliflozin and Vildagliptin, used to manage Type 2 Diabetes Mellitus in adults.
• It helps control blood sugar levels and prevents complications associated with long-term uncontrolled diabetes.
• Jalra-DP Tablet reduces both fasting blood glucose and postprandial blood glucose levels effectively.
• It eliminates excess glucose from the bloodstream through the urine by inhibiting a protein called SGLT2 (sodium-glucose co-transporter 2) in the kidneys. This reduces blood sugar without relying on insulin.
• It also increases the levels of natural substances (incretins) that help to regulate blood sugar by increasing insulin release after meals and decreasing the amount of sugar produced by the liver.
• Jalra-DP Tablet manages blood sugar control, which helps prevent long-term complications such as nerve damage, kidney problems, vision loss, and cardiovascular events.

• Do not take Jalra-DP Tablet if you are allergic to any of its components.
• Inform your doctor if you have any liver/kidney disease, heart problems, or hypertension before taking Jalra-DP Tablet .
• This medicine is not recommended for children as safety and effectiveness have not been established.
• Avoid drinking alcohol while on Jalra-DP Tablet  as it increases the risk of hypoglycemia and lactic acidosis (when the lactic acid increases in the body, which impacts the functioning of various organs in the body).
• Consult your doctor if you are pregnant or breastfeeding.
• Jalra-DP Tablet may cause dizziness; hence, drive or operate machines only if you are alert.
• Inform your doctor about your medical history and the medications you take, including herbs and supplements, to rule out any side effects.